◆ NeutralHNGEGMEDVCYTWST

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Zacks Investment Research·
Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Hinge Health (HNGE) raised its 2026 revenue guidance to $856-$860M following a 53% Q2 revenue jump to $212.8M. The company is expanding beyond its core MSK platform into Migraine Care (450 clients, 5M lives) and acquiring Cylinder Health for $105M to accelerate GI expansion. While growth prospects remain strong with a 30.6% expected growth rate, continued product investments and integration costs could temper margin expansion.

Read Full Article at Zacks Investment Research
← Back to Financial Intelligence